Back to search

Cardiovascular characterization of SD-3211, a novel benzothiazine calcium channel blocker, in isolated rabbit hearts

Data up to Jan 2025

Published1991
Citations16
References12

Total Citations Per Year

Abstract

References (12)

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

1984 • 274 citations

Differences in cardiovascular profile among calcium antagonists

1987 • 108 citations

The expert committee of the World Health Organization on classification of calcium antagonists: The viewpoint of the raporteur

1987 • 71 citations

Synthesis and calcium ion antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzothiazines

1990 • 63 citations

Clinical outcome after treatment of rest angina with calcium blockers: Comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil

1983 • 61 citations

Second-generation calcium antagonists: Search for greater selectivity and versatility

1985 • 58 citations

Novel calcium antagonists. Synthesis and structure-activity relationship studies of benzothiazoline derivatives

1988 • 58 citations

Paradoxical angina after nifedipine: Angiographic documentation

1984 • 34 citations

Electrophysiological Properties of SD-3211, a Novel Putative Ca2+ Antagonist, in Isolated Guinea Pig and Rabbit Hearts

1990 • 28 citations

SD-3211, a Novel Benzothiazine Calcium Antagonist, Alone and in Combination with a Beta-Adrenoceptor Antagonist, Produces Antihypertensive Effects Without Affecting Heart Rate and Atrioventricular Conduction in Conscious Renal Hypertensive Dogs

1991 • 19 citations

Electrophysiologic Effects of a Novel Ca Antagonist, SA2572, in Isolated Rabbit and Guinea Pig Hearts

1988 • 6 citations

The antihypertensive effect of a novel Ca++ antagonist, SD-3211, in rats

1989 • 3 citations

Cited By (0)

Loading...